Drug intelligence / Profile preview

choline chloride

Development stage
Phase 3
Lead developer
Protara Therapeutics
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

Choline chloride is a salt of choline, an essential nutrient that serves as a precursor for the neurotransmitter acetylcholine and membrane phospholipids such as phosphatidylcholine. It is being developed primarily as an intravenous (IV) supplement for patients with intestinal failure who are receiving long-term parenteral nutrition (PN). Because standard PN formulations often lack choline, these patients frequently develop choline deficiency, which can lead to Intestinal Failure-Associated Liver Disease (IFALD), characterized by hepatic steatosis and cholestasis. Protara Therapeutics is advancing IV choline chloride (TARA-001) in Phase 2b/3 clinical trials to address this deficiency and mitigate liver damage. Additionally, choline chloride has been investigated for its potential to modulate DNA methylation in Alzheimer's disease models and as a metabolic imaging agent in the form of deuterated choline for tumor detection.

Brand names
VitaCholine
Other names
choline chloride for injectionIV choline chloride[2H9]-choline chloride
02

Targets

CDP-choline pathway (Kennedy pathway)Acetylcholinesterase

Beyond the preview

Go deeper on choline chloride.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on choline chloride.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call